Bococizumab is a cutting-edge anti-PCSK9 antibody efficiently developed to combat hypercholesterolemia. It therapeutic agent works by the PCSK9 protein, a critical regulator of cholesterol levels. By neutralizing the https://nicolasrxvg022219.wikipresses.com/7255763/bococizumab_a_novel_anti_pcsk9_antibody_for_hypercholesterolemia